Tender offer deadline in $4.3B Roche-Spark deal pushed back for a fifth time.
July 31, 2019 at 10:35 AM EDT
The proposed sale of the Philadelphia gene therapy pioneer continues to be delayed by ongoing regulatory reviews by the FTC and CMA.
